We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

19 hedge funds and large institutions have $4.61M invested in Parnell Pharmaceuticals Holdings Ltd in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

19% more funds holding

Funds holding: 16 → 19 (+3)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

25% less capital invested

Capital invested by funds: $6.17M → $4.61M (-$1.56M)

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
+$716K
2
ECM
Endurant Capital Management
California
+$116K
3
LTFS
Ladenburg Thalmann Financial Services
Florida
+$64.3K
4
AP
Atwood & Palmer
Missouri
+$18.4K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$18.4K

Top Sellers

1
AG
Artal Group
Luxembourg
-$1.06M
2
BlackRock
BlackRock
New York
-$51.4K
3
VKH
Virtu KCG Holdings
New York
-$26K
4
Goldman Sachs
Goldman Sachs
New York
-$8.06K
5
Deutsche Bank
Deutsche Bank
Germany
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.33M – – –
BA
2
BlackRock Advisors
Delaware
$933K -$5.7K -3,100 -0.5%
ECM
3
Endurant Capital Management
California
$732K +$116K +62,900 +16%
SM
4
Sabby Management
Florida
$635K +$716K +389,400 New
BG
5
BlackRock Group
United Kingdom
$354K +$9.56K +5,200 +2%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$240K – – –
BlackRock
7
BlackRock
New York
$138K -$51.4K -27,946 -25%
BIM
8
BlackRock Investment Management
Delaware
$102K – – –
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$60K +$64.3K +35,000 +1,944%
AP
10
Atwood & Palmer
Missouri
$28K +$18.4K +10,000 +145%
Goldman Sachs
11
Goldman Sachs
New York
$19K -$8.06K -4,383 -28%
Cambridge Investment Research Advisors
12
Cambridge Investment Research Advisors
Iowa
$16K +$18.4K +10,000 New
Morgan Stanley
13
Morgan Stanley
New York
$7K +$5.47K +2,977 +291%
UBS Group
14
UBS Group
Switzerland
$7K +$7.39K +4,023 New
Creative Planning
15
Creative Planning
Kansas
$3K +$3.68K +2,000 New
AG
16
Advisor Group
Arizona
$2K +$2.77K +1,507 New
AA
17
AlphaMark Advisors
Kentucky
$1K -$735 -400 -50%
TRCT
18
Tower Research Capital (TRC)
New York
$1K -$656 -357 -34%
Walleye Trading
19
Walleye Trading
New York
$1K +$919 +500 New
AG
20
Artal Group
Luxembourg
– -$1.06M -500,000 Closed
VKH
21
Virtu KCG Holdings
New York
– -$26K -12,285 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– -$8K -3,824 Closed

PARN Hedge Fund Activity: Q2 2016 in Review

19 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q2 2016, worth a combined $4.61M — down 25% from $6.17M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PARN positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $716K. The largest seller was Artal Group, exiting entirely with an estimated $1.06M sold.

  • 19 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q2 2016, up from 16 in Q1 2016.
  • Funds reported $4.61M of Parnell Pharmaceuticals Holdings Ltd stock for Q2 2016, down 25% quarter-over-quarter.
  • 6 funds opened new Parnell Pharmaceuticals Holdings Ltd positions in Q2 2016 and 3 closed out, a net change of +3 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q2 2016 was Sabby Management, an estimated $716K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q2 2016 was Artal Group, an estimated $1.06M sold.

Based on aggregated 13F filings for Q2 2016.